Business & Finance News
Pfizer third-quarter profit jumps 45 percent
U.S. drugmaker Pfizer Inc’s third-quarter profit rose nearly 45 percent, driven by lower tax rates and higher sales of breast cancer drug Ibrance and pneumonia vaccine Prevnar.
